Hans F Stabenau1, Changyu Shen2, Peter Zimetbaum1, Alfred E Buxton1, Larisa G Tereshchenko3, Jonathan W Waks4. 1. Harvard-Thorndike Electrophysiology Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. 2. Smith Center for Outcomes Research in Cardiology, Harvard Medical School, Boston, Massachusetts. 3. Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon. 4. Harvard-Thorndike Electrophysiology Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. Electronic address: jwaks@bidmc.harvard.edu.
Abstract
BACKGROUND: Drugs belonging to diverse therapeutic classes can prolong myocardial refractoriness or slow conduction. These drugs may be effective and well-tolerated, but the risk of sudden cardiac death from torsades de pointes (TdP) remains a major concern. The corrected QT interval has significant limitations when used for risk stratification. Measurement of global electrical heterogeneity (GEH) could help identify the substrate vulnerable to drug-induced ventricular arrhythmias. OBJECTIVE: The purpose of this study was to improve risk stratification for drug-induced TdP by measuring GEH on the electrocardiogram (ECG). METHODS: We analyzed ECG data from a case-control study of patients with a history of drug-induced TdP as well as age- and sex-matched controls. Vectorcardiograms were constructed from ECGs. GEH was measured via the spatial ventricular gradient (SVG) vector (magnitude, azimuth, and elevation). Log odds coefficients for TdP were estimated using multivariable logistic regression. RESULTS: Among 17 cases (47% male; age 58.9 ± 12.5 years) and 17 controls (29% male; age 61.0 ± 12.2 years), 34 ECGs were analyzed. SVG azimuth was significantly different between cases and controls (3.4 vs 22.0 degrees, respectively; P = 0.02). After adjusting for sex and QTc interval, odds of TdP increased by a factor of 3.2 for each 1 SD change in SVG azimuth from the control group mean (95% confidence interval 1.07-9.14; P = .04). QTc was not significant in the multivariable analysis (P = .20). CONCLUSION: SVG azimuth is correlated with a history of drug-induced TdP independent of QTc. GEH measurement may help identify patients at high risk for drug-induced arrhythmias.
BACKGROUND: Drugs belonging to diverse therapeutic classes can prolong myocardial refractoriness or slow conduction. These drugs may be effective and well-tolerated, but the risk of sudden cardiac death from torsades de pointes (TdP) remains a major concern. The corrected QT interval has significant limitations when used for risk stratification. Measurement of global electrical heterogeneity (GEH) could help identify the substrate vulnerable to drug-induced ventricular arrhythmias. OBJECTIVE: The purpose of this study was to improve risk stratification for drug-induced TdP by measuring GEH on the electrocardiogram (ECG). METHODS: We analyzed ECG data from a case-control study of patients with a history of drug-induced TdP as well as age- and sex-matched controls. Vectorcardiograms were constructed from ECGs. GEH was measured via the spatial ventricular gradient (SVG) vector (magnitude, azimuth, and elevation). Log odds coefficients for TdP were estimated using multivariable logistic regression. RESULTS: Among 17 cases (47% male; age 58.9 ± 12.5 years) and 17 controls (29% male; age 61.0 ± 12.2 years), 34 ECGs were analyzed. SVG azimuth was significantly different between cases and controls (3.4 vs 22.0 degrees, respectively; P = 0.02). After adjusting for sex and QTc interval, odds of TdP increased by a factor of 3.2 for each 1 SD change in SVG azimuth from the control group mean (95% confidence interval 1.07-9.14; P = .04). QTc was not significant in the multivariable analysis (P = .20). CONCLUSION: SVG azimuth is correlated with a history of drug-induced TdP independent of QTc. GEH measurement may help identify patients at high risk for drug-induced arrhythmias.
Authors: Jonathan W Waks; Colleen M Sitlani; Elsayed Z Soliman; Muammar Kabir; Elyar Ghafoori; Mary L Biggs; Charles A Henrikson; Nona Sotoodehnia; Tor Biering-Sørensen; Sunil K Agarwal; David S Siscovick; Wendy S Post; Scott D Solomon; Alfred E Buxton; Mark E Josephson; Larisa G Tereshchenko Journal: Circulation Date: 2016-04-14 Impact factor: 29.690
Authors: Jean-Philippe Couderc; Stefan Kaab; Martin Hinterseer; Scott McNitt; Xiaojuan Xia; Anthony Fossa; Britt M Beckmann; Slava Polonsky; Wojciech Zareba Journal: J Clin Pharmacol Date: 2008-10-28 Impact factor: 3.126
Authors: Erick A Perez-Alday; Christopher Hamilton; Annabel Li-Pershing; Jose M Monroy-Trujillo; Michelle Estrella; Stephen M Sozio; Bernard Jaar; Rulan Parekh; Larisa Tereshchenko Journal: Comput Cardiol (2010) Date: 2019-06-24
Authors: Kazi T Haq; Katherine J Lutz; Kyle K Peters; Natalie E Craig; Evan Mitchell; Anish K Desai; Nathan W L Stencel; Elsayed Z Soliman; João A C Lima; Larisa G Tereshchenko Journal: J Electrocardiol Date: 2021-10-02 Impact factor: 1.438